Previous studies have demonstrated that low NEDD4L expression in non-small cell lung cancer, gastric cancer and gliomas is correlated with poor prognoses, while NEDD4L overexpression promotes melanoma tumor growth [28–32]. This evidence concerns the gene NEDD4L and central nervous system cancer.